Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Hongjin Wang
Sun Yat-sen University (SYSU) - Department of Urology
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
81
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
A HER2-Targeted Antibody-Drug Conjugate, RC48-ADC, Exerted Promising Antitumour Efficacy and Safety with Intravesical Instillation in Preclinical Models of Bladder Cancer
Number of pages: 36
Posted: 23 Jan 2023
Xuwei Hong
,
Xu Chen
, Hongjin Wang,
Qingchun Xu
,
Kanghua Xiao
,
Yeqing Liu
,
Guangyao Liu
,
Hong Li
,
Jianmin Fang
,
Yonghai Zhang
and
Tianxin Lin
Sun Yat-sen University (SYSU) - Department of Urology, Sun Yat-sen University (SYSU) - Department of Urology, Sun Yat-sen University (SYSU) - Department of Urology, Sun Yat-sen University (SYSU) - Department of Urology, Sun Yat-sen University (SYSU) - Department of Urology, Sun Yat-sen University (SYSU) - Department of Pathology, South China University of Technology - School of Medicine, Guangzhou Jingke Biotech Group - BioMed Laboratory, Tongji University - School of Life Science and Technology, Sun Yat-sen University (SYSU) - Department of Urology and Sun Yat-sen University (SYSU) - Department of Urology
Downloads
81
(672,257)
View PDF
Download
Abstract:
RC48-ADC, intravesical instillation, non-muscle-invasive bladder cancer, antitumour activity, safety
Feedback
